License Pathogen Reduction Technology (PRT) for Red Blood Cell (RBC) Components to Reduce the Risk of…
FY2024 · complete year · data as of 2026-07-03
A single federal award, with both ends of the trail linked.
Award 75A50124C00046 is a contract from the Department of Health and Human Services, $65.4M obligated, FY2024 to FY2031, for License Pathogen Reduction Technology (PRT) for Red Blood Cell (RBC) Components to Reduce the Risk…. The work is performed in California. It is classified as NAICS 541714 (Research and Development in Biotechnology (except Nanobiotechnology)) and PSC 6505 (Drugs and Biologicals). Source
Description
License Pathogen Reduction Technology (PRT) for Red Blood Cell (RBC) Components to Reduce the Risk of Transfusion-Transmitted Infection (TTI) by Recognized, Emerging, Epidemic, and Endemic Pathogens That Is Capable of Treating Over 10 Million RBC Com